https://www.selleckchem.com/pr....oducts/bismuth-subni
To evaluate the pharmacology, pharmacokinetics, clinical efficacy, safety, dosing, cost, and clinical implications of enfortumab vedotin-ejfv (EV) in the treatment of locally advanced or metastatic urothelial carcinoma (UC). A literature search of PubMed (inception to August 202 was conducted using the terms , and . Data were also obtained from package inserts, meeting abstracts, and ongoing studies from ClinicalTrials.gov. All relevant published articles, package inserts, and meeting abstracts evaluating EV for the treatme
Like
Comment
Share
